• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Astec LifeSciences Limited — Board Meeting, 30-01-2026: Outcome of Board Meeting

    30-01-2026 | 05:47 pm

    Astec LifeSciences' board met, approving Q3 & 9M financial results. Consolidated revenue for Q3 was ₹124.72 Cr, with a loss of ₹15.69 Cr (incl. ₹2.09 Cr one-time charge). Ms. Mugdha Khare resigned as CFO, Mr. Deepak Ochani appointed, effective April 1, 2026.

    No comments yet. Be the first to comment!

    All announcements from Astec LifeSciences Limited